Treatment of conditions involving demyelination
Abstract
The invention provides methods of treating diseases, disorders or injuries involving demyelination and dysmyelination, including multiple sclerosis, by the administration of an Sp35 antagonist. Additional methods include methods for inhibiting the binding of the Sp35 polypeptide with the ErbB2 polypeptide and a method for increasing ErbB2 phosphorylation by contacting oligodendrocytes with an effective amount of a composition comprising an Sp35 antagonist of the invention. Further embodiments of the invention include methods of inhibiting the binding of the Sp35 polypeptide with the ErbB2, increasing ErbB2 phosphorylation and promoting oligodendrocyte differentiation comprising contacting oligodendrocyte or oligodendrcoyte progenitor cells with an ErbB2 binding agent.
Term
Projected expiry 1 December 2026.
- Priority
- Filed
- Published
- Today
- Projected expiry
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO2004085648A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO2006002437A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
7 priority claims, no other members on record
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 741441P | United States of America | – | |
| 74144105 | United States of America | P | |
| 06838776 | European Patent Office (EPO) | A | |
| 068387760 | – | – | – |
| 741441P | – | – | – |
| EP20060838776 | – | – | – |
| US20050741441P | – | – | – |
12 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | |
| Divisional application: reference to earlier applicationAC | AC | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 2543384
- Publication, DOCDB
- 2543384
- Publication, EPODOC
- EP2543384
- Application
- 121569909
- Application, DOCDB
- 12156990
- Application, EPODOC
- EP20120156990
Titles3
- German
- Behandlung von Zuständen mithilfe von Demyelinisation
- English
- Treatment of conditions involving demyelination
- French
- Traitement des conditions impliquant la démyélinisation
Classification
- CPC, 28
- C07K16/28
- A01K67/0275
- A01K67/0276
- A01K2217/075
- A01K2227/105
- A01K2267/0393
- A61K2039/505
- A61P3/02
- C07K14/4702
- A61P9/00
- C07K16/18
- A61P9/10
- C07K16/2863
- A61P21/02
- C07K16/32
- A61P25/00
- C07K16/40
- A61P25/02
- C07K2317/74
- A61P25/14
- C07K2317/75
- A61P25/16
- C07K2317/76
- A61P25/28
- C07K2317/92
- A61P27/02
- C07K2319/30
- C12N15/8509
- IPC, 4
- A61K38 17
- A61K39 00
- A61K39 395
- C07H21 04
Designated states36
- Contracting states, 31
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
- Netherlands (Kingdom of the)
and 7 moreShow fewer
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
- Extension states, 5
- Albania
- Bosnia and Herzegovina
- Croatia
- North Macedonia
- Serbia